Livzon Pharmaceutical repurchases A-shares totaling over RMB 4.2m

Livzon Pharmaceutical Group Co., Ltd. announced a repurchase of 105,200 A-shares on September 10, 2025, through the Shenzhen Stock Exchange. The repurchase price ranged from RMB 39.75 to RMB 40.16 per share, with the total consideration amounting to RMB 4,204,108.

The repurchased shares are intended for cancellation. The announcement confirms that the repurchase adheres to the requirements of the Main Board Listing Rules/GEM Listing Rules and relevant local regulations for share buy-back activities.

The company's A-share capital at the start and end of September 9, 2025, and September 10, 2025, respectively, remained at 604,293,313 shares. The H-share capital remained at 299,807,117 shares. The report also detailed numerous A-share repurchases conducted between December 25, 2024, and September 9, 2025.